167 related articles for article (PubMed ID: 32703222)
21. Overexpression of prostate specific membrane antigen by canine hemangiosarcoma cells provides opportunity for the molecular detection of disease burdens within hemorrhagic body cavity effusions.
Dowling M; Samuelson J; Fadl-Alla B; Pondenis HC; Byrum M; Barger AM; Fan TM
PLoS One; 2019; 14(1):e0210297. PubMed ID: 30601866
[TBL] [Abstract][Full Text] [Related]
22. Prostate-specific membrane antigen expression in melanoma metastases.
Snow H; Hazell S; Francis N; Mohammed K; O'Neill S; Davies E; Mansfield D; Messiou C; Hujairi N; Nicol D; Harrington K; Smith M
J Cutan Pathol; 2020 Dec; 47(12):1115-1122. PubMed ID: 32529651
[TBL] [Abstract][Full Text] [Related]
23. Hepatic Vascular Malformation Mimics PSMA-Positive Prostate Cancer Metastasis.
Hoberück S; Driesnack S; Seppelt D; Michler E; Hölscher T; Kotzerke J
Clin Nucl Med; 2020 Jun; 45(6):e283-e284. PubMed ID: 32332316
[TBL] [Abstract][Full Text] [Related]
24. Oligometastases in prostate cancer : Metabolic response in follow-up PSMA-PET-CTs after hypofractionated IGRT.
Baumann R; Koncz M; Luetzen U; Krause F; Dunst J
Strahlenther Onkol; 2018 Apr; 194(4):318-324. PubMed ID: 29181556
[TBL] [Abstract][Full Text] [Related]
25. Heterogeneity of prostate-specific membrane antigen (PSMA) expression in prostate carcinoma with distant metastasis.
Mannweiler S; Amersdorfer P; Trajanoski S; Terrett JA; King D; Mehes G
Pathol Oncol Res; 2009 Jun; 15(2):167-72. PubMed ID: 18802790
[TBL] [Abstract][Full Text] [Related]
26. The utility of PSMA and PSA immunohistochemistry in the cytologic diagnosis of metastatic prostate carcinoma.
Bernacki KD; Fields KL; Roh MH
Diagn Cytopathol; 2014 Jul; 42(7):570-5. PubMed ID: 24273068
[TBL] [Abstract][Full Text] [Related]
27. Neovascular Prostate-Specific Membrane Antigen Expression Is Associated with Improved Overall Survival under Palliative Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma.
Stock K; Steinestel K; Wiesch R; Mikesch JH; Hansmeier A; Trautmann M; Beller N; Rehkämper J; Wardelmann E; Heitkötter B; Hartmann W; Sperveslage J; Huss S
Biomed Res Int; 2017; 2017():2847303. PubMed ID: 29209626
[TBL] [Abstract][Full Text] [Related]
28. Prostate-specific Membrane Antigen PET: Clinical Utility in Prostate Cancer, Normal Patterns, Pearls, and Pitfalls.
Hofman MS; Hicks RJ; Maurer T; Eiber M
Radiographics; 2018; 38(1):200-217. PubMed ID: 29320333
[TBL] [Abstract][Full Text] [Related]
29. A prospective randomized multicentre study of the impact of gallium-68 prostate-specific membrane antigen (PSMA) PET/CT imaging for staging high-risk prostate cancer prior to curative-intent surgery or radiotherapy (proPSMA study): clinical trial protocol.
Hofman MS; Murphy DG; Williams SG; Nzenza T; Herschtal A; Lourenco RA; Bailey DL; Budd R; Hicks RJ; Francis RJ; Lawrentschuk N
BJU Int; 2018 Nov; 122(5):783-793. PubMed ID: 29726071
[TBL] [Abstract][Full Text] [Related]
30. High expression of prostate-specific membrane antigen in the tumor-associated neo-vasculature is associated with worse prognosis in squamous cell carcinoma of the oral cavity.
Haffner MC; Laimer J; Chaux A; Schäfer G; Obrist P; Brunner A; Kronberger IE; Laimer K; Gurel B; Koller JB; Seifarth C; Zelger B; Klocker H; Rasse M; Doppler W; Bander NH
Mod Pathol; 2012 Aug; 25(8):1079-85. PubMed ID: 22460809
[TBL] [Abstract][Full Text] [Related]
31. Prostate-specific membrane antigen (PSMA) immunoexpression in the neovasculature of colorectal carcinoma in Egyptian patients.
Abdel-Hadi M; Ismail Y; Younis L
Pathol Res Pract; 2014 Nov; 210(11):759-63. PubMed ID: 24951241
[TBL] [Abstract][Full Text] [Related]
32. Cold Kit for Prostate-Specific Membrane Antigen (PSMA) PET Imaging: Phase 1 Study of
Hofman MS; Eu P; Jackson P; Hong E; Binns D; Iravani A; Murphy D; Mitchell C; Siva S; Hicks RJ; Young JD; Blower PJ; Mullen GE
J Nucl Med; 2018 Apr; 59(4):625-631. PubMed ID: 28986512
[No Abstract] [Full Text] [Related]
33. Molecular analysis of circulating tumor cells of metastatic castration-resistant Prostate Cancer Patients receiving
Kessel K; Seifert R; Weckesser M; Roll W; Humberg V; Schlack K; Bögemann M; Bernemann C; Rahbar K
Theranostics; 2020; 10(17):7645-7655. PubMed ID: 32685010
[No Abstract] [Full Text] [Related]
34. Heterogeneous Flare in Prostate-specific Membrane Antigen Positron Emission Tomography Tracer Uptake with Initiation of Androgen Pathway Blockade in Metastatic Prostate Cancer.
Aggarwal R; Wei X; Kim W; Small EJ; Ryan CJ; Carroll P; Cooperberg M; Evans MJ; Hope T
Eur Urol Oncol; 2018 May; 1(1):78-82. PubMed ID: 31100231
[TBL] [Abstract][Full Text] [Related]
35. PSMA: a game changer in the diagnosis and treatment of advanced prostate cancer.
Parsi M; Desai MH; Desai D; Singhal S; Khandwala PM; Potdar RR
Med Oncol; 2021 Jun; 38(8):89. PubMed ID: 34181109
[TBL] [Abstract][Full Text] [Related]
36. PSMA expression: a potential ally for the pathologist in prostate cancer diagnosis.
Bravaccini S; Puccetti M; Bocchini M; Ravaioli S; Celli M; Scarpi E; De Giorgi U; Tumedei MM; Raulli G; Cardinale L; Paganelli G
Sci Rep; 2018 Mar; 8(1):4254. PubMed ID: 29523813
[TBL] [Abstract][Full Text] [Related]
37. A Rare Case of Omentum Invasive Prostate Cancer: Staging With PSMA PET/CT Imaging and Response to Systemic Therapy.
Ladwa R; Gustafson S; McCaffrey E; Miles K; O'Byrne K
Clin Nucl Med; 2017 Jun; 42(6):e311-e312. PubMed ID: 28240670
[TBL] [Abstract][Full Text] [Related]
38. PSMA Expression in Differentiated Thyroid Cancer: Association With Radioiodine, 18FDG Uptake, and Patient Outcome.
Ciappuccini R; Saguet-Rysanek V; Giffard F; Licaj I; Dorbeau M; Clarisse B; Poulain L; Bardet S
J Clin Endocrinol Metab; 2021 Nov; 106(12):3536-3545. PubMed ID: 34331544
[TBL] [Abstract][Full Text] [Related]
39. Prostate-Specific Membrane Antigen Positron Emission Tomography-Computed Tomography for Prostate Cancer: Distribution of Disease and Implications for Radiation Therapy Planning.
Gupta SK; Watson T; Denham J; Shakespeare TP; Rutherford N; McLeod N; Picton K; Ainsworth P; Bonaventura T; Martin JM
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):701-709. PubMed ID: 29280465
[TBL] [Abstract][Full Text] [Related]
40. Biochemical characterization of prostate-specific membrane antigen from canine prostate carcinoma cells.
Wu LY; Johnson JM; Simmons JK; Mendes DE; Geruntho JJ; Liu T; Dirksen WP; Rosol TJ; Davis WC; Berkman CE
Prostate; 2014 May; 74(5):451-7. PubMed ID: 24449207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]